History of antibody therapy for non-Hodgkin’s lymphoma
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (6) , 1-5
- https://doi.org/10.1053/j.seminoncol.2003.10.002
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2002
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.The Journal of cell biology, 1993
- VDJ recombinationImmunology Today, 1992
- Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemiaAmerican Journal of Hematology, 1992
- Somatic generation of antibody diversityNature, 1983
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Croonian lecture.—On immunity with special reference to cell lifeProceedings of the Royal Society of London, 1900
- Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei ThierenDeutsche Medizinische Wochenschrift (1946), 1890